Anatara's CEO, Steve Lydeamore will be presenting to investors during the Bioshares Biotech Summit this Friday, and at a Monsoon Communications Twilight Investor Briefing event in Melbourne during August. Any investors interested in attending these presentations are invited to reach out.

Details and registration links are summarised below:

Bioshares Biotech Summit

Steve will speak in a session on Gut and the Microbiome alongside Microba and Atmo Biosciences:

* Friday, 26th July 2019
* 5:00pm to 6:00pm
* Skyline, Queenstown, New Zealand

To see the Bioshares program and event information, visit:

Monsoon Communications Twilight Investor Briefing

Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals, alongside AdAlta Ltd:

* Thursday 22nd August 2019
* 4.15pm for 4.30pm
* FB Rice Boardroom, Level 14, 90 Collins Street, Melbourne

To register, contact

About Anatara Lifesciences Ltd

Anatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit



Investor and Media inquiries

Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172

Sue MacLeman
Anatara Lifesciences Ltd
T: +61-437-211-200

Related Companies

Anatara Lifesciences Ltd

Related Industry Topics:
Biotech Drugs & OTC Health & Pharm General